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The influence of serotonin- and other genes on impulsive
behavioral aggression and cognitive impulsivity in children with
attention-deficit/hyperactivity disorder (ADHD): Findings from a
family-based association test (FBAT) analysis
Abstract
ABSTRACT: BACKGROUND: Low serotonergic (5-HT) activity correlates with increased
impulsive-aggressive behavior, while the opposite association may apply to cognitive impulsiveness.
Both types of impulsivity are associated with attention-deficit/hyperactivity disorder (ADHD), and
genes of functional significance for the 5-HT system are implicated in this disorder. Here we
demonstrate the separation of aggressive and cognitive components of impulsivity from symptom
ratings and test their association with 5-HT and functionally related genes using a family-based
association test (FBAT-PC). METHODS: Our sample consisted of 1180 offspring from 607 families
from the International Multicenter ADHD Genetics (IMAGE) study. Impulsive symptoms were assessed
using the long forms of the Conners and the Strengths and Difficulties parent and teacher questionnaires.
Factor analysis showed that the symptoms aggregated into parent- and teacher-rated behavioral and
cognitive impulsivity. We then selected 582 single nucleotide polymorphisms (SNPs) from 14 genes
directly or indirectly related to 5-HT function. Associations between these SNPs and the
behavioral/cognitive groupings of impulsive symptoms were evaluated using the FBAT-PC approach.
RESULTS: In the FBAT-PC analysis for cognitive impulsivity 2 SNPs from the gene encoding
phenylethanolamine N-methyltransferase (PNMT, the rate-limiting enzyme for adrenalin synthesis)
attained corrected gene-wide significance. Nominal significance was shown for 12 SNPs from BDNF,
DRD1, HTR1E, HTR2A, HTR3B, DAT1/SLC6A3, and TPH2 genes replicating reported associations
with ADHD. For overt aggressive impulsivity nominal significance was shown for 6 SNPs from BDNF,
DRD4, HTR1E, PNMT, and TPH2 genes that have also been reported to be associated with ADHD.
Associations for cognitive impulsivity with a SERT/SLC6A4 variant (STin2: 12 repeats) and aggressive
behavioral impulsivity with a DRD4 variant (exon 3: 3 repeats) are also described. DISCUSSION: A
genetic influence on monoaminergic involvement in impulsivity shown by children with ADHD was
found. There were trends for separate and overlapping influences on impulsive-aggressive behavior and
cognitive impulsivity, where an association with PNMT (and arousal mechanisms affected by its
activity) was more clearly involved in the latter. Serotonergic and dopaminergic mechanisms were
implicated in both forms of impulsivity with a wider range of serotonergic mechanisms (each with a
small effect) potentially influencing cognitive impulsivity. These preliminary results should be followed
up with an examination of environmental influences and associations with performance on tests of
impulsivity in the laboratory.
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Abstract
Background: Low serotonergic (5-HT) activity correlates with increased impulsive-aggressive
behavior, while the opposite association may apply to cognitive impulsiveness. Both types of
impulsivity are associated with attention-deficit/hyperactivity disorder (ADHD), and genes of
functional significance for the 5-HT system are implicated in this disorder. Here we demonstrate
the separation of aggressive and cognitive components of impulsivity from symptom ratings and test
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(FBAT-PC).
Methods: Our sample consisted of 1180 offspring from 607 families from the International
Multicenter ADHD Genetics (IMAGE) study. Impulsive symptoms were assessed using the long
forms of the Conners and the Strengths and Difficulties parent and teacher questionnaires. Factor
analysis showed that the symptoms aggregated into parent- and teacher-rated behavioral and
cognitive impulsivity. We then selected 582 single nucleotide polymorphisms (SNPs) from 14 genes
directly or indirectly related to 5-HT function. Associations between these SNPs and the
behavioral/cognitive groupings of impulsive symptoms were evaluated using the FBAT-PC
approach.
Results: In the FBAT-PC analysis for cognitive impulsivity 2 SNPs from the gene encoding
phenylethanolamine N-methyltransferase (PNMT, the rate-limiting enzyme for adrenalin synthesis)
attained corrected gene-wide significance. Nominal significance was shown for 12 SNPs from
BDNF, DRD1, HTR1E, HTR2A, HTR3B, DAT1/SLC6A3, and TPH2 genes replicating reported
associations with ADHD. For overt aggressive impulsivity nominal significance was shown for 6
SNPs from BDNF, DRD4, HTR1E, PNMT, and TPH2 genes that have also been reported to be
associated with ADHD. Associations for cognitive impulsivity with a SERT/SLC6A4 variant (STin2:
12 repeats) and aggressive behavioral impulsivity with a DRD4 variant (exon 3: 3 repeats) are also
described.
Discussion: A genetic influence on monoaminergic involvement in impulsivity shown by children
with ADHD was found. There were trends for separate and overlapping influences on impulsive-
aggressive behavior and cognitive impulsivity, where an association with PNMT (and arousal
mechanisms affected by its activity) was more clearly involved in the latter. Serotonergic and
dopaminergic mechanisms were implicated in both forms of impulsivity with a wider range of
serotonergic mechanisms (each with a small effect) potentially influencing cognitive impulsivity.
These preliminary results should be followed up with an examination of environmental influences
and associations with performance on tests of impulsivity in the laboratory.
Background
Impulsive actions usually damage not only the victim but
often their perpetrator. In fights, suicide or fire-setting the
aggressive component is immediately apparent. But the
risky and overly rapid decisions behind these actions
demonstrate a cognitive component that is often revealed
in gambling and seeking immediate gratification. Impul-
sivity is a core construct of many mental disorders [1]. In
particular, it is an essential component of the diagnosis of
the most prevalent form of attention-deficit/hyperactivity
disorder ADHD, namely the 'combined type' (ADHD-ct:
[2]).
Across a group of youngsters with ADHD-ct there are
many who show abrupt bursts of impulsive aggression
(related to conduct disorder), but many others who
(merely) make rapid and wrong decisions in everyday life,
or abhor delayed gratification to their cost [3]. Here, we
consider that these two forms of impulsivity may have dis-
tinct pathophysiological features with relation to ADHD.
In particular, this article focuses on serotonin activity, [4])
and heritable features of ADHD, where a 70–80% herita-
bility has been clearly demonstrated [5].
Impulsivity has been briefly and broadly defined as
"action without foresight" [6]. More generally impulsivity
covers actions that appear "poorly conceived, prematurely
expressed, and are unduly risky or inappropriate to the sit-
uation. They often result in undesirable consequences"
[7]. Impulsivity has been linked strongly to outbreaks of
aggression in adults (here considered as overt impulsive
behavioral aggression) that are associated with increased
5-HT2a platelet receptor binding (Bmax and Kd),
decreased 5-HT1a postmortem binding and low serotonin
(5-HT) activity [8-10]. While some studies have failed to
find the same relationship of low 5-HT activity with
aggression in children [11-13] many others do report an
inverse relationship [14-16] sensitive to pharmacotherapy
[17]. It may be that the phenocopy for aggression has not
always fully developed at the time of study. Impulsive
aggression reacts to provocation and is marked after 5-HT
synthesis reduction following tryptophan depletion [18].
Indeed, Halperin's group, in showing an apparently pro-
tective effect of high 5-HT activity, recently proposed that
low activity is important if not sufficient for the emer-
gence of aggression. Consistent with the developmental
expression of the trait they reported that low 5-HT respon-Page 2 of 14
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cial personality disorder 9 years later [19].
More differentiated views of impulsiveness [20] suggest
that, as well as aggressive and behavioral impulsiveness
associated with emotional lability and motor control,
there are also cognitive or attention-related elements [21];
for example, there are the cognitive expressions of impul-
siveness that are associated with failures of inhibitory
executive functions ("executive attention", [22]). Typi-
cally decisions are made hastily and lead to maladaptive
outcomes. Such impulsivity is epitomized by errors of
commission on a discrimination or Go/no-go task, and is
perhaps reflected in more motivationally-based domains
where response choice is driven by early reinforcement
[23]. This form of cognitive impulsiveness may be
regarded as a form of impaired selective attention. How-
ever, it is a result of overly rapid, inadequate information
processing that leads to inappropriate action. This should
be contrasted with absences of conventional attentive
processes (inattentiveness) that would normally bring the
searchlight, the focus of selective processing to stimulus
identification. Inattention leads to the omission of a
response. Thus it is important to distinguish the term inat-
tention, as it is usually understood, from impulsive (cog-
nitive) processing that risks non-adaptive responses. Such
impulsive decisions about the moment-to-moment
organization and planning of responses to stimuli are
commonly made by both younger [24] and older subjects
with ADHD [25].
The goal of the current study is to disentangle the relation-
ship between aggressive impulsivity of a more behavioral
nature and cognitive impulsivity in ADHD by exploring
the differential patterns of association of these two forms
of impulsivity with genes that have significance for 5-HT
function, a putative neurobiological marker of impulsiv-
ity. There is mounting evidence that polymorphisms for
genes influencing several features of the 5-HT system are
associated with ADHD [4], and a case has been made for
a differential involvement of 5-HT activity in impulsive
aggressive behavior and cognitive impulsivity [26]. For
example, in one study increases of platelet 5-HT trans-
porter affinity in 20 children with ADHD correlated with
ratings of externalizing behavior, but decreases of affinity
were associated with distractibility, impulsivity and the
difficulty to withhold a prepotent response on the stop-
task [27]. Similarly a study of adolescent prisoners
described opposite correlations of 5-HT activity with
crime and other measures of impulsivity [28]. On tasks
assessing impulsivity (see [29]), errors of commission are
typical of youngsters with ADHD who show an underacti-
vation in the right frontal cortices [30]. An impairment is
expressed in similar regions of young healthy subjects
treated with a tryptophan-depleting drink [31].
We therefore explored whether there would be common-
alities and differences between the two forms of impulsiv-
ity and 5-HT genes controlling the activation or
suppression of activity within 5-HT systems, along with
other genetic markers of neuronal activity (e.g.
dopamine) which influence or are influenced by the activ-
ity in 5-HT systems [32].
Methods
Participants
The initial data-set contained 614 families with 776 Euro-
pean Caucasian cases of DSM-IV ADHD-ct and 706 sib-
lings without the disorder. These families had been
recruited as part of the International Multicenter ADHD
Genetics Project (IMAGE: details in [33]). They had been
included in the first stage of genotyping, which investi-
gated 51 candidate genes for the disorder [24]. In this
sample, 1180 offspring from 607 families had the neces-
sary genotype and phenotype data to be included in the
analysis. These individuals were recruited from 12 special-
ist clinics in 8 European countries (Belgium, Germany,
Ireland, Israel, Spain, Switzerland, the Netherlands and
the United Kingdom). The sample was aged 5–17 years on
entry to the study (mean ages for both groups were 10.9 y:
table 1). In 4 families the case did not meet the strict cri-
teria for ADHD-ct. However, these families were included
Table 1: Sample Characteristics
Number of genotyped families 607
Total number of genotyped people 2337
Number of genotyped parents 1157
Number of genotyped offspring 1180
Number of offspring per family
1 124
2 402
3 72
4 9
Gender of offspring:
Male 793 (67.2%)
Female 387 (32.8%)
Average age of offspring (Standard Deviation) 10.9 (3.0)
Number of affected offspring 603
Origin:
Northern Europe 882
Spain 99
Israel 199
Note: Diagnosis was restricted to children (ADHD combined type) 
and not systematically attempted with parents.Page 3 of 14
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tentive or hyperactive-impulsive ADHD or 2) were just
below the threshold for meeting the ADHD-ct criteria. As
genetic association studies are underpowered, we felt that
including these individuals in the analysis would be ben-
eficial by keeping the sample size higher.
Exclusion criteria were genetic or medical disorders asso-
ciated with behavior mimicking ADHD, autism, epilepsy,
IQ<70, and the absence of a medication-free period per-
mitting evaluation in the previous 2 years. Approval for
the study was obtained from ethical review boards at each
clinic, which were registered with and monitored by the
National Institutes of Health, and were in accordance with
the Code of Ethics of the World Medical Association (Dec-
laration of Helsinki).
Assessments: diagnosis and impulsivity
Clinical assessments were made during medication free
periods or based on recall of such periods in the last 2
years. Diagnoses of ADHD-ct were based on the semi-
structured Parental Account of Children's Symptoms
(PACS; [34]). Interviewers received formal training in
administration of the PACS. PACS includes 4 subscales,
representing the different DSM-IV categories for ADHD
and disruptive behaviors (hyperactivity, defiance, emo-
tionality, and comorbid disorders). An age adjustment for
symptom thresholds is built into the PACS algorithm.
Detailed descriptions of the child's typical behavior in a
range of specified situations defined by the context (e.g.
play) or the behavior shown (e.g. crying) that had
occurred in the previous week and in the previous year
were rated on a 4-point scale for frequency and severity.
Situational pervasiveness was determined by the different
situations investigated within the interview and the pres-
ence of at least one symptom in each domain reported in
the Conners teacher rating (CTRS) ADHD sub-scales.
Autism spectrum disorders were screened for all children
using the Social Communication Questionnaire (≥ 15) in
conjunction with the pro-social scale from the Strengths
and Difficulties Questionnaire (SDQ ≤ 4). Inter-rater reli-
ability was high with product-moment correlations for
pairs of interviewers ranging from 0.79 to 0.96. A mean
kappa coefficient across all the sites of 0.88 (range
0.71–1.00) and an average agreement percentage of
96.6% (range 78.6–100) were obtained. Concurrent
validity of the PACS diagnosis was confirmed by the bise-
rial correlation between PACS diagnosis of ADHD-ct with
the CTRS N-scale (18 DSM-items) scores at 0.68 and with
Conners' Parent rating scale (CPRS) N-scale scores at 0.78
[34-36].
For both the cases and the siblings, parents completed the
long form of the revised CPRS (80 items) and teachers the
long form of the revised CTRS (59 items [37]). Both also
completed the SDQ (25 items). The SDQ scores are based
on 5 different scales: emotional problems, behavior prob-
lems, hyperactivity/inattention, peer problems, and
prosocial behavior. The scale is well validated and has
good test-retest reliability (α = .85: [38,39]). From these
parent and teacher rating scales (CPRS, CTRS, SDQ) we
selected symptoms with impulsive behavioral aggression
and cognitive impulsiveness. The 47 items selected are
listed in tables 2 and 3 where the source of each item is
indicated by the code in the legend.
Gene selection
We selected 14 genes with 582 single nucleotide polymor-
phisms (SNPs) from the data available from the IMAGE
study for the core analysis reported here. For the 5-HT sys-
tem, markers for pre- and post-synaptic receptors (HTR1A,
HTR1B, HTR1E, HTR2A, HTR3B), and synaptic availabil-
ity controlled by synthesis (TPH2) and re-uptake (SERT/
SLC6A4) were chosen. We reasoned that some dopamin-
ergic (DA) biomarkers should be included in view of
widespread interactions between 5-HT and DA systems in
the brain (reviews in [32,40]). These included SNPs for
the receptors DRD1, DRD4 and DAT1/SLC6A3. There
have been reports of associations for each of these genes
with ADHD that were subsequently replicated (reviews:
[4,5,41]). We also decided to include 4 genes for compar-
ison that might be expected to have a less specific out-
come on neural activity and behavior than those targeting
neurotransmitter synthesis and receptor function (BDNF,
NURR-1, FADS2, and PNMT: see discussion). For an addi-
tional analysis genotype information on repeat polymor-
phisms (microsatellites) was available for the DRD4
(exon 3 variable number tandem repeat [VNTR]), the
DAT1/SLC6A3 (3' untranslated region VNTR), the SERT/
SLC6A4 (a VNTR polymorphism in intron 2: STin2) and
an in/del promoter polymorphism (5-HTTLPR), from an
analysis based on 1116 ADHD families.
DNA and SNP collection
The DNA sample used here is a part of a larger genetic
sample from the IMAGE study. Details of the DNA isola-
tion and SNP selection can be found elsewhere [33].
Briefly, blood samples were sent to Rutgers University Cell
and DNA repository, New Jersey, U.S.A., where DNA was
extracted. In a limited number of cases where individuals
were not able to supply a blood sample, DNA was
extracted from a mouth swab sample at the SGDP labora-
tories in London, U.K. [42]. DNA stocks were collated in
London where they were stored, organized and plated out
for further analysis. Geneservice Ltd. Cambridge (UK) per-
formed whole genome amplification on all samples with
less than 100 μg stock DNA, using the REPLI-g kit (Quia-
gen Ltd., Crawley, UK). DNA samples were arrayed into
96-well plates at a concentration of 50 ng/μl and delivered
to Illumina Inc. (San Diego, US) under dry ice. A total ofPage 4 of 14
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Behavioral and Brain Functions 2008, 4:48 http://www.behavioralandbrainfunctions.com/content/4/1/48Table 2: Principle components analysis (oblique rotation) of 47 items of impulsivity: Parent and teacher ratings from Conners and 
SDQ questionnaires (CP, SP and CT, ST, respectively).
Part 1 – The aggressive behavioral form of impulsivity (factors 1 and 2)
Item Descriptor Factor 1 Factor 2
CP47 Temper outbursts 0.950
CP21 Loses temper 0.893
SP5 Often has temper tantrums 0.896
CP31 Irritable 0.840
CP57 Touchy or easily annoyed 0.859
CP77 Mood changes quickly 0.820
CP1 Angry and resentful 0.916
CP40 Actively defies or refuses to 0.780
CP11 Argues with adults 0.826
CP68 Demands to be met at once 0.598
CP28 Excitable, impulsive 0.356
CP70 Spiteful or vindictive 1.000
SP12 Often fights with other children 0.588
CP66 Disturbs other children 0.294
CP64 Get upset if someone rearranges 0.947
SP7 Generally obedient, usually ... -0.510
ST5 Often has temper tantrums 1.000
CT7 Temper outbursts; explosive, 0.972
CT45 Demands must be met at once 0.898
CT54 Mood changes quickly, drastically 0.945
CT37 Argues with adults 0.957
CT55 Interrupts or intrudes on others 0.655
CT8 Excitable, impulsive 0.661
CT29 Has difficulty waiting in turn 0.606
CT46 Blurts out answers to question 0.674
ST12 Often fights with other children 0.922
CT47 Spiteful or vindictive 0.989Page 5 of 14
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a larger set of SNPs/genes described elsewhere [33]. These
SNPs were selected as tag-SNPs to explain the linkage dis-
equilibrium structure throughout the gene. Additional
polymorphisms genotyped were the repeat polymor-
phisms in DRD4, SLC6A3/DAT1 and SLC6A4/SERT. Gen-
otyping was by simple sequence analysis on agarose gel, as
described previously [43-45]. Each polymorphism was
evaluated to ensure Hardy-Weinberg equilibrium, ini-
tially at α = 0.0001, then at α = 0.05. Data cleaning proce-
dures were performed previously on the entire IMAGE set
of SNP data and have been described [33].
Analytical strategy: family based association test – 
principle components (FBAT-PC)
To determine that the 47 symptoms selected for associa-
tion analysis would indeed group into major factors of
cognitive and aggressive behavioral impulsivity we ran a
preliminary factor analysis (Promax) with an oblique
rotation in the SAS statistical package. This rotation is in
line with clinical experience that subjects present concur-
rently with symptoms from different dimensions [46].
Four factors based on an eigenvalue cutoff of = 1.0 con-
firmed these groupings: namely, A) impulsive aggressive
behavior based on 1) parent ratings, 2) teacher ratings,
and B) cognitive impulsivity rated by 3) parents, and 4)
teachers (tables 2 and 3). The names of these groupings
reflect the items that emphasize temper outbursts and
anger (2A), and distraction (despite understanding the
task) that reflects responding to inappropriate stimuli
(commission rather than omission: 2B). A look at tables 2
and 3 shows that few variables loading on one factor had
strong weightings on the other. Three examples for factors
1 and 2 are "excitable impulsive" (CP28), "disturbs other
children" (CP66) and "generally obedient" (SP7). Of
interest is the item "blurts out answers before the question
is finished" that loads modestly on factor 2 (CT46) with a
similar value to that on factor 3 (CP80). This item could
be construed as an example of impulsive behavior overly-
ing a cognitively impulsive decision. A previous factor
analysis of ADHD symptom domains in 10–14 y-old chil-
dren confirmed that behavioral impulsivity related to
aggression and delinquency, while inattentive items
related to hyperactivity [47].
We then performed separate association analyses at each
SNP for each of the two groupings while applying the
FBAT-PC approach. The FBAT-PC approach generates a
composite phenotype by using a weighted sum of the
individual phenotypes (details in [48,49], for applications
see [50,51]). The weights for this composite phenotype
are selected to maximize the heritability at each SNP.
Screening procedures were employed to limit the number
of statistical tests performed using the PBAT computer
program. An outline of the screening procedure can be
summarized as follows: 1) the conditional mean model is
used to calculate the power to detect an association using
the composite phenotype; 2) SNP/genetic model combi-
nations are selected based on the power to detect an asso-
ciation and then ranked; 3) for the top ten power rankings
in the FBAT-PC statistics are calculated for the selected
SNP/genetic model combinations and their associated
phenotypes; 4) the results are adjusted for multiple com-
parisons using the False Discovery Rate (FDR: [52]. For
these analyses, we considered additive (0), dominant (1)
and recessive (2) genetic models. We required our results
to have at least 20 informative families.
Results
Sample description
Table 1 summarizes the characteristics of the IMAGE sam-
ple used in this analysis. There were 607 families, each
with between 1 and 4 offspring who had complete geno-
type and phenotype information. Two thirds of the off-
spring were male and 603 had a diagnosis of ADHD-ct.
The predominant ethnic make-up of the sample was
northern European with subsets from Spain and Israel. As
family-based tests are robust to population stratification
all individuals were included in the analysis. Previous
CT20 Leaves seat in classroom or 0.544
ST7 Generally obedient, usually -0.700
ST25 Good attention span sees -0.958
Variance Explained 14.6 13.2
Eigen Value 20.4 4.42
Squared Multiple Correlation 0.92 0.90
Table 2: Principle components analysis (oblique rotation) of 47 items of impulsivity: Parent and teacher ratings from Conners and 
SDQ questionnaires (CP, SP and CT, ST, respectively). (Continued)Page 6 of 14
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not change substantially when the Spanish and Israeli
groups were removed.
FBAT-PC analysis
We applied the FBAT-PC approach to the items making up
'impulsive aggression' and 'cognitive impulsivity' varia-
bles separately. For both analyses the associations were
ranked by power and the first ten were selected for further
consideration. No SNPs survived gene-wide corrections
for an association with both forms of impulsivity.
For impulsive behavioral aggression there were 6 SNPs
from 5 genes that attained nominal significance (p ≤ 0.05:
table 4). These genes were BDNF, DRD4, HTR1E, TPH2,
and PNMT.
For cognitive impulsivity one SNP from the PNMT gene
attained gene-wide statistical significance following an
FDR correction for multiple testing in both additive and
dominant models (p ≤ 0.05: table 4). In addition, 12
SNPs from 7 genes attained nominal significance (p ≤
0.05) for an association with cognitive impulsivity. These
genes were BDNF, DAT1/SLC6A3, DRD1, HTR1E, HTR2A,
HTR3B, and TPH2.
Genotype information on repeat polymorphisms (micro-
satellites) was available for the DRD4 (exon 3, VNTR), the
DAT1/SLC6A3 (3' untranslated region VNTR) and the
SERT/SLC6A4 (a VNTR in intron 2: STin2) and an in/del
promoter polymorphism (5-HTTLPR) from an analysis
based on 1116 ADHD families. There were nominally sig-
nificant associations on an additive model for the 3-repeat
DRD4 allele (p = 0.014) with impulsive aggressive behav-
ior, and the SERT VNTR (STin2: 12 vs. 9 and 10 repeat alle-
les; p = 0.050) with cognitive impulsivity. Other tests for
association (e.g. for the promoter region, 5-HTTLPR long
and short repeats) proved not to be significant.
Having identified the SNP/model combinations listed in
table 4, we examined the associations with ADHD affec-
tion status. In addition to being the only gene where there
was gene-wide significance, PNMT was also the only gene
that was nominally associated with ADHD affection sta-
tus. SNP rs200173 had associations with ADHD affection
status for both the additive and dominant genetic models
(unadjusted p-value = 0.0065 and 0.012 respectively) and
rs2934966 had an association with the dominant model
(unadjusted p-value = 0.0458).
Discussion
After separating the 47 items from the SDQ and Conners
symptom ratings into the two dimensions of aggressive
and cognitive impulsivity, we used the FBAT-PC software
to evaluate their possible associations with 582 SNPs dis-
Table 3: Principle components analysis (oblique rotation) of 47 
items of impulsivity: Parent and teacher ratings from Conners 
and SDQ questionnaires (CP, SP and CT, ST, respectively).
Part 2 -The cognitive form of impulsivity (factors 3 and 4)
Item Descriptor Factor 3 Factor 4
CP79 Easily distracted by extraneous ... 0.886
CP37 Fails to finish things started 1.000
SP15 Easily distracted, poor concentration 0.924
CP12 Fails to complete assignment 0.938
CP48 Get distracted even when instructed 0.827
CP29 Does not follow instructions through 0.872
CP80 Blurts out answers to questions 0.694
CP42 Has difficulty waiting in line 0.601
SP21 Thinks things out before acting -0.818
SP25 Good attention span, sees ... -0.961
CT26 Inattentive easily distracted 0.865
CT52 Distractibility, or attention span poor 0.858
ST15 Easily distracted, poor concentration 0.842
CT58 Easily distracted by extraneous 0.713
CT57 Does not follow instructions through 1.000
CT17 Fails to finish things started 0.922
ST21 Thinks things out before acting -0.481
ST25 Good attention span sees -0.958
Variance Explained 16.0 12.8
Eigen Value 2.53 1.07
Squared Multiple Correlation 0.87 0.88
Item-codes from scales include C, Conners; S, Strengths and 
difficulties; P, Parent; T, Teacher. The combination of factors 1 and 2 
relate to the behavioral aggression component, and factors 3 and 4 
relate to the cognitive impulsivity component. Note: If represented as 
the sum, each form of impulsivity explained 28–29% of the variance. 
As the informants' ratings correlated highly the true contribution of 
the components would be approximately halved.Page 7 of 14
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Table 4: FBAT-PC results for behavioral (factors 1 + 2) and cognitive impulsivity (factors 3 + 4)
Factors 1 & 2 (behavioral impulsivity)
Gene SNP Allele Frequency Model Under/Over Transmitted Inform. Families p-value Power FDR p-value
Nominal significance
BDNF rs7103411 C 0.20927 2 O 91 0.021263 9 0.10746
BDNF rs10767664 T 0.20889 2 O 87 0.021492 10 0.10746
DRD4 rs3758653 C 0.17287 2 O 52 0.008178 4 0.08178
HTR1E rs1406946 A 0.44805 1 U 338 0.031630 1 0.26692
PNMT rs2934966 T 0.04997 0 O 102 0.027007 2 0.10349
TPH2 rs6582071 A 0.22517 2 U 95 0.010714 10 0.10714
Factors 3 & 4 (cognitive impulsivity)
Gene wide significance
PNMT rs200173 A 0.02383 0 O 40 0.003818 1 0.00936
PNMT rs200173 A 0.02383 1 O 40 0.004680 4 0.00936
Nominal significance
BDNF rs13306221 A 0.05762 1 O 140 0.042211 6 0.22758
DRD1 rs686 G 0.35975 0 U 427 0.006978 6 0.06978
DRD1 rs686 G 0.35975 1 U 336 0.023762 8 0.11881
HTR1E rs1406946 A 0.44805 1 O 338 0.034898 1 0.38387
HTR2A rs6561333 T 0.43307 2 U 288 0.012237 4 0.12237
HTR2A rs1923886 C 0.41760 2 U 278 0.033097 5 0.16548
HTR3B rs1672717 C 0.39106 2 U 234 0.040249 4 0.20125
HTR3B rs3782025 C 0.45063 2 U 266 0.026497 6 0.20125
SLC6A3 rs13189021 T 0.23494 2 U 103 0.018997 9 0.18997
TPH2 rs1352250 A 0.43298 1 O 359 0.011413 2 0.06598
TPH2 rs10879352 T 0.39596 1 O 364 0.015048 4 0.06598
TPH2 rs1487275 G 0.28429 1 O 356 0.019794 9 0.06598
Model: 0 = additive, 1 = dominant, 2 = recessive
Under/Over Transmitted: O = over-transmitted, U = under-transmitted
Behavioral and Brain Functions 2008, 4:48 http://www.behavioralandbrainfunctions.com/content/4/1/48tributed through 14 relevant genes. The genes were
selected because their expression affects 5-HT activity and
closely-related neural functions and they have previously
been reported to be associated with a diagnosis of ADHD.
The focus on 5-HT-related features was based on descrip-
tions of the relevance of this transmitter to the expression
of impulsivity [4,26,53] and for the preferential transmis-
sion of polymorphisms influencing 5-HT function in
ADHD (see introduction). Gene-wide significance was
achieved only for a variant of the gene encoding the
enzyme for the synthesis of adrenalin (PNMT) in cogni-
tive impulsivity. However nominal significance was
shown for genes affecting a range of elements of the 5-HT
and DA systems in both forms of impulsivity, and that
have previously been reported to be associated with
ADHD.
The absence of prominent associations for neurotransmit-
ter markers, apart from that with adrenalin synthesis
through PNMT variants, was surprising. A gene-wide sig-
nificant association was found for one SNP for PNMT
with cognitive impulsivity, and a second was nominally
associated with behavioral aggressive impulsivity from
the 4 SNPs for PNMT that were examined. In both
instances the trait was over-expressed (table 4). This was
partly anticipated by a similar significant finding in a can-
didate gene analysis for association with ADHD from the
IMAGE sample [33]. PNMT is the rate-limiting enzyme in
the synthesis of adrenalin that has transmitter and endo-
crine influences on brain function which can be stimula-
tory or inhibitory, respectively [54]. The association of
adrenalin with CNS arousal is significant in the context of
the common attribution of hypoarousal to ADHD func-
tion (review: [55]). Further, one might anticipate that
arousal levels would be pertinent to both forms of impul-
sivity under investigation here, but especially the cogni-
tive attention-related form that could be a precursor to the
behavioral, aggression-related form. Indeed, adrenalin
levels in ADHD children are usually lower than normal
[56-58] unless they show anxiety [59-61]. Low levels are
associated with restlessness and aggressive outbursts [62].
Response to treatment with methylphenidate tends to
normalize levels of adrenalin [58,63] and improve auto-
nomic measures of low arousal (skin conductance levels:
[64]). Thus there is broad support for a widespread role
for impaired function of arousal and adrenalin systems in
ADHD and the impulsivity that is characteristic of the dis-
order. From our current results, we would predict that this
could be based in an altered expression or function of the
PNMT gene. Considering the potential parallel involve-
ment of 5-HT systems in impulsivity, and the demon-
strated role of 5-HT in the control of autonomic function
[65] it would be useful to look for tagging between vari-
ants influencing PNMT and 5-HT receptors.
In agreement with our expectations, analyses of the two
forms of impulsivity are reflected at least nominally in
similar but also in different associations with the genetic
markers for monoamine activity. For the 5-HT system,
association with synthesis (TPH2) and receptor-mediated
mechanisms (HTR1E) may be relevant to both forms of
impulsivity. Indeed the same SNP for HTR1E (rs1406946)
was nominally associated with both types of impulsive-
ness in the dominant transmission model. It was over-
expressed in the cognitive and under-expressed in the
behavioral or aggressive form of impulsivity (table 4). The
difference for 5-HT function is one of emphasis, with a
number of markers pointing to small effects on synthesis
(TPH2 3 SNPs), pre-and post-synaptic receptors (HTR1E,
HTR2A, HTR3B: 5 SNPs) and reuptake (SERT: STin2) for
cognitive (not behavioral) impulsivity. For cognitive
impulsivity 4 SNPs for receptors (apart from HTR1E) were
under-expressed in a recessive model, whereas the availa-
bility of 5-HT (e.g. TPH2 in a dominant model) was influ-
enced by over-expression of relevant alleles. For the DA
system, nominally significant markers were found for
both types of impulsivity, but while the emphasis for the
behavioral/aggressive form was on DRD4 (one SNP and
in particular the 3-repeat allele was over-expressed), cog-
nitive impulsivity was nominally associated with uptake
(DAT1: 1 SNP) and the D1 receptor (DRD1: 2 SNPs),
which were all under-expressed. Based on their anatomi-
cal distributions, this could reflect top-down mesocortical
and bottom-up mesolimbic mechanisms of control,
respectively [66].
The 5-HT component implies a potential influence of 5-
HT activity in those children with ADHD who show
aggressive behavioral and cognitive impulsivity both
through its availability (TPH2-mediated synthesis and
SERT-mediated uptake), and the efficacy of 5-HT action
via the 5-HT2 and 5-HT1 receptor families [67]. General-
izing in this context, activation of the 5-HT1B and 5-HT2A
receptors tend to be 'stimulatory', while the 5-HT1A and
5-HT2C sites are more often 'inhibitory' [68]. The 5-HT
receptor mediated influence obtains especial significance
with regard to the interaction of 5-HT with the DA system
considering that ADHD is often considered a 'hypo-
dopaminergic' disorder [69,70] and the 5-HT and DA sys-
tems interact directly and widely through subcortical and
cortical regions [32]. Even if the genetic effects reported
here are modest, there is intriguing support for our
hypothesis of opposing types of interactions of DA and 5-
HT in the two forms of impulsivity. Thus, in aggressive
behavioral impulsivity a DRD4 SNP was overexpressed
while those for HTR1E and TPH were underexpressed. In
contrast in cognitive impulsivity SNPs for DRD1 and
DAT1 were underexpressed while others for TPH2 and
HTR1E were overexpressed.Page 9 of 14
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have also been reported recently for children and adults
with ADHD [71] and correlations with hyperactive/
impulsive symptoms were described for a normal popula-
tion [72]. However, other groups have seen no association
[73,74]. Unfortunately, little is known about the func-
tional role of 5-HT1E sites that make up a quarter of those
binding 5-HT in the forebrain in autoradiographic post-
mortem studies of cortical and hippocampal regions
(CA3-4 >> CA1 [75]). In contrast, 5-HT3 receptors have
been more widely studied, and are abundant in limbic
and frontal regions [76]. In contrast to the inhibitory
functions attributed to HT1 receptors, stimulation of HT3
sites enhances DA release [77]. Thus the nominal signifi-
cance of the association of 4 SNPs for stimulatory recep-
tors (HT2A and HT3B) with cognitive impulsivity is
consistent with the opposing effects of 5-HT activity on
the two forms of impulsiveness proposed in the introduc-
tion.
The presence of 3 SNPs for TPH2 with near gene-wide sig-
nificant associations with cognitive impulsiveness along
with the significant relationship for a SERT allele (as also
indicated by [78]) would suggest that markers for the pre-
synaptic availability of 5-HT merit continued attention.
The importance of this is illustrated, for example, by the
functional consequence of changes in SERT activity as
expressed with the short allele. In this instance the bind-
ing potential of 5-HT receptors may alter, as demonstrated
for the 5-HT1a binding site [79]. In turn changes at this
binding site (with inhibitory function) would strongly
modulate transmitter release in DA systems. Considering
the well-known interactions of these two monoaminergic
systems [32], the potential for tagging between genetic
loci should be sought in future studies.
Lastly, we studied SNPs representing 3 other genes
(BDNF, FADS2, NURR1/NR4A2) on the grounds that
their activity could influence neurotransmission includ-
ing that based on 5-HT, and that some associations with
ADHD have been reported [33]. Brain derived neuro-
trophic factor (BDNF) facilitates the development of the
release mechanisms for several neurotransmitters. It is
known to have age-dependent effects on 5-HT transporter
function [80]. In BDNF-knockout mice this led to reduced
5-HT metabolism [81] and aggressive impulsive behavior
[82]. A nominal association with both forms of impul-
siveness emerged from the present analysis, that may
reflect a small effect on the development of monoamine
systems in general for cases of ADHD that particularly
reflect an etiology of delayed maturation [83]. However,
there is not much support for an association of BDNF
markers with the diagnosis of ADHD [84]. NURR1/
NR4A2 is an orphan nuclear receptor and transcription
factor crucial to the genetic control of development of DA
neurons [85,86]. The expression of NURR1/NR4A2 is
essential for the induction of several markers of DA activ-
ity (e.g. tyrosine hydroxylase). However, there was no evi-
dence here for the altered expression or function of
NURR1/NR4A2. Finally, fatty-acid desaturase gene-2
(FADS2) is involved in regulating membrane synthesis
and function and at least one polymorphism has been
closely associated with ADHD [87]. The ratio of omega-3
to omega-6 unsaturated fatty acids in neural membranes
certainly influences their fluidity and the ability of neu-
rons to conduct efficiently: this is a problem for ADHD
with documented white matter anomalies [88] and poten-
tially for the function of oligodendrocytes responsible for
membrane synthesis [89]. But we found no evidence that
the FADS2 markers investigated were associated with the
types of impulsivity studied here.
Limitations of the study
The design of the study involved recruiting children and
adolescents who showed to a greater or lesser extent the
features of impulsivity we sought. Alternative approaches
could contrast children with and without these features,
and compare pre-, post-pubertal and young adult subjects
to investigate putative developmental changes in gene
expression. A comparison of groups with high comorbid-
ity for externalizing or internalizing symptoms would be
instructive both for the integrity of our concepts of impul-
sivity in affect and cognition, as well as for identifying the
grounds for separating subgroups of ADHD with 'comor-
bid features'. We would also point out the severe limita-
tions of interpreting symptoms based on lay responses to
questionnaires. It is important that the preliminary work
described here be extended to neuropsychological testing
that would contrast not only provoked aggression with
impulsive decision making, but incorporate the role of
reinforcement (e.g. delayed gratification).
There are also several limitations with regard to the sam-
ple and genotyping. Although this sample is reasonably
sized for moderate genetic effects, the number of individ-
uals could be larger to detect the modest genetic effects
that one would expect to observe here. In addition, indi-
viduals enrolled in the IMAGE study are from several dif-
ferent places throughout Europe, including Spain and
Israel. Although the FBAT statistic is robust to population
stratification, the PBAT screening algorithm can be
affected by this. Finally, current genome-wide scans are
suggesting many genes that one could not have suspected
of being of interest a short time ago. Therefore some can-
didate genes that may now seem important were not
included in this analysis.
Conclusion
ADHD is a highly heterogeneous disorder: it has been
argued that there are potentially multiple variants of thePage 10 of 14
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logical signatures and neuropsychological and behavioral
markers [90]. Consequently, it has been suggested that
one of the key goals for ADHD research should be to parse
that heterogeneity, to create more neurobiologically
homogeneous sub-groupings so as to provide more
refined diagnostic criteria and more specific treatment tar-
gets [91]. One manifestation of such a strategy is the
search for endophenotypes, for pathophysiologic markers
that mediate the pathways from genetic and environmen-
tal risk to disorder [92]. From this perspective the current
differentiation between two types of impulsiveness on the
basis of their associated genes and their behavioral char-
acteristics both highlight these constructs as putative
endophenotypes for ADHD and encourage further
research to explore the possibility that two 'subtypes' of
ADHD might exist marked by different types of impulsive-
ness. The one has a strong basis in motivation and emo-
tion with expression dependent on a degree of motor
disinhibition (aggressive-behavioral impulsivity), and the
other reflects poor executive control of endogenous atten-
tion-related processes that can underlie risky decision-
making in several functional domains (cognitive impul-
sivity).
In particular, this study has taken an exploratory look at
whether some SNPs from genes related to 5-HT function
are associated with symptom ratings that reflect aggressive
behavioral and cognitive impulsivity. Clearly different
results could emerge from the study of other genes/SNPs
as they become available. These SNPs cover genes for only
four of the 22 types 5-HT receptor identified. There are
indications that other receptors could be involved (e.g. 5-
HT1D, 5-HT4, 5-HT6, 5-HT7: [71,93]. Complementary to
the present study, one using cognitive impulsivity meas-
ures from neuropsychological tests (e.g. continuous per-
formance and flanker tasks) would be necessary before
one could draw firm conclusions about the influence of
heritable features of the 5-HT system on cognitive deci-
sion-making processes.
Nonetheless, based on ratings of impulsive symptoms, in
the first instance this study strongly implicates genetic
influences in ADHD on the synthesis of adrenalin and by
implication on the degree of arousal influencing the
organization and expression of behavior. In the second
instance we report a genetic influence on the expression of
SERT, along with potential, small effects of TPH2, 5-
HT1E, 5-HT2A, DAT1, DA D1 and D4 receptors promi-
nently expressed in limbic and association cortices and
implicated in the initiation of impulsive processes and
their expression by young people with ADHD. These fea-
tures of 3 monoamine systems and two types of impulsiv-
ity may be regarded as 'intermediate phenotypes' for the
psychopathology of combined-type ADHD. The useful-
ness of the FBAT-PC approach in the context of dissecting
impulsivity in ADHD has been demonstrated, and war-
rants further, closer study using measures of impulsivity
defined by neuropsychological task performance.
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